抗菌剂
风险分析(工程)
抗生素耐药性
医学
生化工程
计算机科学
生物
工程类
抗生素
微生物学
作者
Chew-Li Moo,Shun-Kai Yang,Khatijah Yusoff,Mokrish Ajat,Warren Thomas,Aisha Abushelaibi,Swee‐Hua Erin Lim,Kok‐Song Lai
标识
DOI:10.2174/1570163816666190304122219
摘要
Antimicrobials are useful compounds intended to eradicate or stop the growth of harmful microorganisms. The sustained increase in the rates of antimicrobial resistance (AMR) worldwide is worrying and poses a major public health threat. The development of new antimicrobial agents is one of the critical approaches to overcome AMR. However, in the race towards developing alternative approaches to combat AMR, it appears that the scientific community is falling behind when pitched against the evolutionary capacity of multi-drug resistant (MDR) bacteria. Although the “pioneering strategy” of discovering completely new drugs is a rational approach, the time and effort taken are considerable, the process of drug development could instead be expedited if efforts were concentrated on enhancing the efficacy of existing antimicrobials through: combination therapies; bacteriophage therapy; antimicrobial adjuvants therapy or the application of nanotechnology. This review will briefly detail the causes and mechanisms of AMR as background, and then provide insights into a novel, future emerging or evolving strategies that are currently being evaluated and which may be developed in the future to tackle the progression of AMR.
科研通智能强力驱动
Strongly Powered by AbleSci AI